Mismatch Between Kidney Disease Burden and Nephrology Workforce in Mexico

Journal
Kidney International Reports
ISSN
2468-0249
Date Issued
2020
Author(s)
Arrigunaga, Sofía De
Cuadra, Montserrat
Type
text::journal::journal article
DOI
URL
Abstract
End-stage kidney disease (ESKD) is highly prevalent worldwide and is associated with high mortality, morbidity, and cost. It has been estimated that, in 2010, a total of 2.6 million people received kidney replacement therapy (KRT) globally, and that between 4.9 and 9.7 million patients needed KRT. For the Latin American and Caribbean regions, the number of patients receiving versus needing KRT was 373,000 versus 626,000. 1 Although a national dialysis registry is lacking in Mexico, in 2005, it was estimated that there were approximately 130,000 patients with ESKD and that only half of them had access to KRT. 2 Furthermore, the burden of disease attributed to chronic kidney disease (CKD) has increased dramatically. Among all diseases, CKD went from being ranked #16 in 1990 to #2 in 2013 for years of life lost due to premature death.© 2020 International Society of Nephrology. Published by Elsevier Inc.